Surgical treatment of posthemorrhagic infantile hydrocephalus

L Massimi1, C Di Rocco

  • 1Department of Pediatric Neurosurgery, Sacro Cuore Catoholic University, Policlinico A. Gemelli, Rome, Italy - lmassimi@email.it.

Minerva Pediatrica
|September 21, 2013
PubMed

Insights

Post-hemorrhagic hydrocephalus (PHH) affects surviving preterm infants. While shunts are common, they have high complication rates, and endoscopic options offer limited success, often requiring reoperation.

Area of Science:

  • Neuroscience
  • Pediatric Surgery
  • Neonatology

Background:

  • Post-hemorrhagic hydrocephalus (PHH) incidence remains stable despite improved perinatal care, with more survivors developing this condition.
  • Symptomatic ventriculomegaly, often following severe preterm brain hemorrhage (Papile's grade III-IV), necessitates treatment.

Purpose of the Study:

  • To review current treatment strategies for PHH, focusing on temporary measures, shunting, and neuroendoscopic interventions.
  • To analyze the efficacy and complication rates associated with various PHH treatments, including ventriculo-peritoneal shunts and endoscopic procedures.

Main Methods:

  • Review of literature on PHH management, including medical therapies, transient surgical maneuvers, ventriculo-peritoneal shunting, and neuroendoscopy.
  • Analysis of complication rates (infection, obstruction, erosion) associated with shunts and reoperation rates for endoscopic procedures.

Main Results:

  • Ventriculo-peritoneal shunts are the primary surgical treatment but have high complication rates, especially in low-weight infants, leading to frequent reoperations (approx. 30%).
  • Neuroendoscopy can address hemorrhage complications (blood clots, cysts) and isolated ventricles, potentially avoiding multiple shunts.
  • Endoscopic third ventriculostomy, a definitive endoscopic option, is effective in only about one-third of PHH cases, often necessitating reoperation due to CSF re-absorption issues, subarachnoid obstruction, or low intracranial pressure.

Conclusions:

  • PHH management remains challenging, with significant reoperation rates for both shunt-based and endoscopic treatments.
  • While neuroendoscopy offers benefits in managing complications, its definitive success rate for PHH is limited.
  • Further research is needed to improve the long-term efficacy of PHH treatments and reduce the need for multiple interventions.

Related Concept Videos